These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
368 related articles for article (PubMed ID: 20813865)
41. Targeting the WNK-SPAK/OSR1 Pathway and Cation-Chloride Cotransporters for the Therapy of Stroke. Josiah SS; Meor Azlan NF; Zhang J Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513812 [TBL] [Abstract][Full Text] [Related]
42. SPAK and WNK kinases: a new target for blood pressure treatment? Glover M; O'shaughnessy KM Curr Opin Nephrol Hypertens; 2011 Jan; 20(1):16-22. PubMed ID: 21088576 [TBL] [Abstract][Full Text] [Related]
43. The regulation of salt transport and blood pressure by the WNK-SPAK/OSR1 signalling pathway. Richardson C; Alessi DR J Cell Sci; 2008 Oct; 121(Pt 20):3293-304. PubMed ID: 18843116 [TBL] [Abstract][Full Text] [Related]
44. NKCC2 is activated in Milan hypertensive rats contributing to the maintenance of salt-sensitive hypertension. Carmosino M; Rizzo F; Ferrari P; Torielli L; Ferrandi M; Bianchi G; Svelto M; Valenti G Pflugers Arch; 2011 Aug; 462(2):281-91. PubMed ID: 21553016 [TBL] [Abstract][Full Text] [Related]
45. Dietary salt regulates the phosphorylation of OSR1/SPAK kinases and the sodium chloride cotransporter through aldosterone. Chiga M; Rai T; Yang SS; Ohta A; Takizawa T; Sasaki S; Uchida S Kidney Int; 2008 Dec; 74(11):1403-9. PubMed ID: 18800028 [TBL] [Abstract][Full Text] [Related]
46. The WNK-SPAK/OSR1 Kinases and the Cation-Chloride Cotransporters as Therapeutic Targets for Neurological Diseases. Huang H; Song S; Banerjee S; Jiang T; Zhang J; Kahle KT; Sun D; Zhang Z Aging Dis; 2019 Jun; 10(3):626-636. PubMed ID: 31165006 [TBL] [Abstract][Full Text] [Related]
47. Characterization of SPAK and OSR1, regulatory kinases of the Na-K-2Cl cotransporter. Gagnon KB; England R; Delpire E Mol Cell Biol; 2006 Jan; 26(2):689-98. PubMed ID: 16382158 [TBL] [Abstract][Full Text] [Related]
48. The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases. Vitari AC; Deak M; Morrice NA; Alessi DR Biochem J; 2005 Oct; 391(Pt 1):17-24. PubMed ID: 16083423 [TBL] [Abstract][Full Text] [Related]
49. A single binding motif is required for SPAK activation of the Na-K-2Cl cotransporter. Gagnon KB; England R; Delpire E Cell Physiol Biochem; 2007; 20(1-4):131-42. PubMed ID: 17595523 [TBL] [Abstract][Full Text] [Related]
50. Decreased blood pressure and vascular smooth muscle tone in mice lacking basolateral Na(+)-K(+)-2Cl(-) cotransporter. Meyer JW; Flagella M; Sutliff RL; Lorenz JN; Nieman ML; Weber CS; Paul RJ; Shull GE Am J Physiol Heart Circ Physiol; 2002 Nov; 283(5):H1846-55. PubMed ID: 12384462 [TBL] [Abstract][Full Text] [Related]
51. Integrated compensatory network is activated in the absence of NCC phosphorylation. Grimm PR; Lazo-Fernandez Y; Delpire E; Wall SM; Dorsey SG; Weinman EJ; Coleman R; Wade JB; Welling PA J Clin Invest; 2015 May; 125(5):2136-50. PubMed ID: 25893600 [TBL] [Abstract][Full Text] [Related]
52. WNK1 and OSR1 regulate the Na+, K+, 2Cl- cotransporter in HeLa cells. Anselmo AN; Earnest S; Chen W; Juang YC; Kim SC; Zhao Y; Cobb MH Proc Natl Acad Sci U S A; 2006 Jul; 103(29):10883-8. PubMed ID: 16832045 [TBL] [Abstract][Full Text] [Related]
53. SPAK and OSR1 dependent down-regulation of murine renal outer medullary K channel ROMK1. Elvira B; Munoz C; Borras J; Chen H; Warsi J; Ajay SS; Shumilina E; Lang F Kidney Blood Press Res; 2014; 39(4):353-60. PubMed ID: 25322850 [TBL] [Abstract][Full Text] [Related]
54. WNK2 kinase is a novel regulator of essential neuronal cation-chloride cotransporters. Rinehart J; Vázquez N; Kahle KT; Hodson CA; Ring AM; Gulcicek EE; Louvi A; Bobadilla NA; Gamba G; Lifton RP J Biol Chem; 2011 Aug; 286(34):30171-80. PubMed ID: 21733846 [TBL] [Abstract][Full Text] [Related]
55. Perspective of future drugs targeting sterile 20/SPS1-related proline/alanine-rich kinase for blood pressure control. Lin GM; Liu PY; Wu CF; Wang WB; Han CL World J Cardiol; 2015 Jun; 7(6):306-10. PubMed ID: 26131334 [TBL] [Abstract][Full Text] [Related]
56. Mouse model of type II Bartter's syndrome. I. Upregulation of thiazide-sensitive Na-Cl cotransport activity. Cantone A; Yang X; Yan Q; Giebisch G; Hebert SC; Wang T Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1366-72. PubMed ID: 18385266 [TBL] [Abstract][Full Text] [Related]
57. Volume sensitivity of cation-Cl- cotransporters is modulated by the interaction of two kinases: Ste20-related proline-alanine-rich kinase and WNK4. Gagnon KB; England R; Delpire E Am J Physiol Cell Physiol; 2006 Jan; 290(1):C134-42. PubMed ID: 15930150 [TBL] [Abstract][Full Text] [Related]
58. Stimulation of human and mouse erythrocyte Na(+)-K(+)-2Cl(-) cotransport by osmotic shrinkage does not involve AMP-activated protein kinase, but is associated with STE20/SPS1-related proline/alanine-rich kinase activation. Sid B; Miranda L; Vertommen D; Viollet B; Rider MH J Physiol; 2010 Jul; 588(Pt 13):2315-28. PubMed ID: 20442269 [TBL] [Abstract][Full Text] [Related]
59. Nephron-Specific Disruption of Nitric Oxide Synthase 3 Causes Hypertension and Impaired Salt Excretion. Gao Y; Stuart D; Takahishi T; Kohan DE J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29997131 [TBL] [Abstract][Full Text] [Related]
60. [WNK-SPAK-SLC12A signal cascade is a new therapeutic target for hypertension]. Kikuchi E; Mori T; Uchida S Nihon Rinsho; 2015 Sep; 73(9):1597-605. PubMed ID: 26394527 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]